Efficacy and safety of biologics and small molecules for psoriasis in pediatric and geriatric populations. Part II: focus on elderly patients

M Megna, E Camela, T Battista, L Genco… - Expert Opinion on …, 2023 - Taylor & Francis
Introduction The management of moderate-to-severe forms of psoriasis is becoming a
frequent concern in geriatric age due to the higher risk to develop treatment adverse events …

New onset and exacerbations of psoriasis following COVID-19 vaccines: a systematic review

PC Wu, IH Huang, CW Wang, CC Tsai… - American journal of …, 2022 - Springer
Background Vaccination has been promoted to control viral transmission in response to the
coronavirus disease 2019 (COVID-19) pandemic. Cases of new-onset or exacerbation of …

Microneedles as a momentous platform for psoriasis therapy and diagnosis: A state-of-the-art review

BHJ Gowda, MG Ahmed, U Hani, P Kesharwani… - International Journal of …, 2023 - Elsevier
Psoriasis is a chronic, autoimmune, and non-communicable skin disease with a worldwide
prevalence rate of 2–3%, creating an economic burden on global health. Some significant …

Nutritional therapy in persons suffering from psoriasis

J Garbicz, B Całyniuk, M Górski, M Buczkowska… - Nutrients, 2021 - mdpi.com
Psoriasis is a chronic inflammatory skin disease. Immunological, genetic, and environmental
factors, including diet, play a part in the pathogenesis of psoriasis. Metabolic syndrome or its …

[HTML][HTML] Efficacy and safety of total glucosides of paeony in the treatment of 5 types of inflammatory arthritis: a systematic review and meta-analysis

K Yang, L Zeng, Z Long, Q He, W Xiang, A Ge… - Pharmacological …, 2023 - Elsevier
Objective To evaluate efficacy and safety of total glucosides of paeony in the treatment of 5
types of inflammatory arthritis Methods Databases such as Pubmed, Cochran Library …

Chemokine profile in psoriasis patients in correlation with disease severity and pruritus

D Purzycka-Bohdan, B Nedoszytko, M Zabłotna… - International Journal of …, 2022 - mdpi.com
Psoriasis (PsO) is a chronic, immune-mediated, inflammatory skin disease associated in
most cases with pruritus. Chemokines seem to play a significant role in PsO pathogenesis …

Metabolic comorbidities of psoriasis

DE Branisteanu, RA Pirvulescu… - Experimental and …, 2022 - spandidos-publications.com
Psoriasis is a chronic inflammatory and immune‑mediated condition, which is no longer
considered as being limited to the skin, but may affect the entire body. Epidemiological …

Etiopathogenesis of Psoriasis: Integration of Proposed Theories

BF Hernandez-Nicols, JJ Robledo-Pulido… - Immunological …, 2024 - Taylor & Francis
Psoriasis is a chronic inflammatory disease characterized by squamous and erythematous
plaques on the skin and the involvement of the immune system. Global prevalence for …

Inhibition of mitochondrial translation ameliorates imiquimod-induced psoriasis-like skin inflammation by targeting Vγ4+ γδ T cells

A Dhillon-LaBrooy, KL Braband, E Tantawy… - Journal of Investigative …, 2024 - Elsevier
Psoriasis is an inflammatory skin disorder that is characterized by keratinocyte
hyperproliferation in response to immune cell infiltration and cytokine secretion in the …

Metabolic rewiring of macrophages by epidermal-derived lactate promotes sterile inflammation in the murine skin

U Ayyangar, A Karkhanis, H Tay, AFB Afandi… - The EMBO …, 2024 - embopress.org
Dysregulated macrophage responses and changes in tissue metabolism are hallmarks of
chronic inflammation in the skin. However, the metabolic cues that direct and support …